Celanese (CE) Reports Q1 Earnings: What Key Metrics Have to Say

Celanese (CE) reported $2.34 billion in revenue for the quarter ended March 2026, representing a year-over-year decline of 2.2%. EPS of $0.85 for the same period compares to $0.57 a year ago.The reported revenue represents a surprise of +3.19% over the Zacks Consensus Estimate of $2.26 billion. With the consensus EPS estimate being $0.88, the EPS surprise was -3.41%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Celanese performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Volume - Acetyl Chain: -7% compared to the -7% average estimate based on two analysts.Volume - Engineered Materials: 3% versus the two-analyst average estimate of 3.2%.Price - Acetyl Chain: -4% versus the two-analyst average estimate of -4.8%.Net Sales- Acetyl Chain: $1.04 billion compared to the $996.49 million average estimate based on two analysts. The reported number represents a change of -7.2% year over year.Net Sales- Intersegment Eliminations: $-24 million compared to the $-15.12 million average estimate based on two analysts. The reported number represents a change of +71.4% year over year.Net Sales- Engineered Materials: $1.33 billion versus $1.27 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +3% change.Operating EBITDA- Acetyl Chain: $194 million versus $178.05 million estimated by two analysts on average.Operating EBITDA- Other Activities: $-63 million versus the two-analyst average estimate of $-59.64 million.Operating EBITDA- Engineered Materials: $324 million versus $322.04 million estimated by two analysts on average.View all Key Company Metrics for Celanese here>>>Shares of Celanese have returned +7.8% over the past month versus the Zacks S&P 500 composite's +9.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks